Shares of 10x Genomics (TXG) have gained 14.7% over the past four weeks to close the last trading session at $9.49, but there could still be a solid upside left in the stock if short-term price ...

Fintel reports that on July 10, 2024, Deutsche Bank downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from Buy to Hold. Analyst Price Forecast Suggests 121.84% Upside As of July 4 ...

Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results tomorrow after the bell. Here’s what investors should know. 10x Genomics beat analysts’ revenue expectations by 3. ...

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for. 10x Genomics missed analysts’ revenue expectations by 5% last quarter ...